000			02124 a2200613 4500
005			20250516231100.0
264		0	_c20160225
008			201602s 0 0 eng d
022			_a1600-0641
024	7		_a10.1016/j.jhep.2014.08.021 _2doi
040			_aNLM _beng _cNLM
100	1		_aMarcellin, Patrick
245	0	0	_aTelbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy. _h[electronic resource]
260			_bJournal of hepatology _cJan 2015
300			_a41-7 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAntiviral Agents _xadverse effects
650	0	4	_aDNA, Viral _xanalysis
650	0	4	_aDrug Carriers
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGlobal Health
650	0	4	_aHepatitis B e Antigens _ximmunology
650	0	4	_aHepatitis B virus _xgenetics
650	0	4	_aHepatitis B, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aInterferon-alpha _xadverse effects
650	0	4	_aMale
650	0	4	_aPeripheral Nervous System Diseases _xdiagnosis
650	0	4	_aPolyethylene Glycols _xadverse effects
650	0	4	_aRecombinant Proteins _xadverse effects
650	0	4	_aTelbivudine
650	0	4	_aThymidine _xadverse effects
700	1		_aWursthorn, Karsten
700	1		_aWedemeyer, Heiner
700	1		_aChuang, Wan-Long
700	1		_aLau, George
700	1		_aAvila, Claudio
700	1		_aPeng, Cheng-Yuan
700	1		_aGane, Edward
700	1		_aLim, Seng Gee
700	1		_aFainboim, Hugo
700	1		_aFoster, Graham R
700	1		_aSafadi, Rifaat
700	1		_aRizzetto, Mario
700	1		_aManns, Michael
700	1		_aBao, Weibin
700	1		_aTrylesinski, Aldo
700	1		_aNaoumov, Nikolai
773	0		_tJournal of hepatology _gvol. 62 _gno. 1 _gp. 41-7
856	4	0	_uhttps://doi.org/10.1016/j.jhep.2014.08.021 _zAvailable from publisher's website
999			_c24125605 _d24125605